Company intelligence / Profile preview

Caerus Medical

Ownership: Private
Development stage: Commercial

Overview

Caerus Medical developed an AI-powered platform ("LumbAI"/"LumbarMR") that assists radiologists and spine professionals in diagnosing lumbar spine disorders on MRI scans. The technology supports faster and more accurate low back pain diagnosis using artificial intelligence. In March 2025, the company was acquired by Gleamer to expand their suite of AI-based radiology tools.

Therapeutic areas: Neurology
Modalities: DeviceArtificial intelligence software (for diagnostic support)
Industry: Medical Imaging

Partnerships

Academic collaborations with France Imageries TerritoiresCHU de ToulouseCHUM de MontréalClinique du Parc de LyonCHU de StrasbourgClinique du Sport de BordeauxGroupe Imagerie Médical Dunkerquois

Beyond the preview

Go deeper on Caerus Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caerus Medical.

Explore the full profile